Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2021 Filed Mar 9, 2021 21:18 UTC |
Farrington ThomasEVP and CIO
|
GrantOrdinary Shares | 3,758 | $41.82 | $157,159.56 |
DisclosureSEC source: 0001585364-21-000030 · wf-form4_161534267503733.xml · nonDerivative · entry 1 Farrington Thomas · CIK 0001398276 · EVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,984 F1 · kind: Vesting of performance-based restricted stock units granted on March 8, 2018. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:17 UTC |
Willis RobertEVP & CHRO
|
Tax withholdingOrdinary Shares | 363 | $41.82 | $15,180.66 |
DisclosureSEC source: 0001585364-21-000028 · wf-form4_161534262842908.xml · nonDerivative · entry 6 Willis Robert · CIK 0001770124 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,571 Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:17 UTC |
Willis RobertEVP & CHRO
|
Exercise / conversionOrdinary Shares | 697 | $41.82 | $29,148.54 |
DisclosureSEC source: 0001585364-21-000028 · wf-form4_161534262842908.xml · nonDerivative · entry 5 Willis Robert · CIK 0001770124 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of service-based restricted stock units granted on March 8, 2018. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:17 UTC |
Willis RobertEVP & CHRO
|
Tax withholdingOrdinary Shares | 980 | $41.82 | $40,983.60 |
DisclosureSEC source: 0001585364-21-000028 · wf-form4_161534262842908.xml · nonDerivative · entry 2 Willis Robert · CIK 0001770124 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,959 Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:17 UTC |
Willis RobertEVP & CHRO
|
GrantOrdinary Shares | 1,884 | $41.82 | $78,788.88 |
DisclosureSEC source: 0001585364-21-000028 · wf-form4_161534262842908.xml · nonDerivative · entry 1 Willis Robert · CIK 0001770124 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,939 F1 · kind: Vesting of performance-based restricted stock units granted on March 8, 2018. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:17 UTC |
Quinn GrainneEVP, Chief Medical Officer
|
Tax withholdingOrdinary Shares | 1,083 | $41.82 | $45,291.06 |
DisclosureSEC source: 0001585364-21-000027 · wf-form4_161534260400653.xml · nonDerivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,658 Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:17 UTC |
Quinn GrainneEVP, Chief Medical Officer
|
GrantOrdinary Shares | 2,082 | $41.82 | $87,069.24 |
DisclosureSEC source: 0001585364-21-000027 · wf-form4_161534260400653.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,741 F1 · kind: Vesting of performance-based restricted stock units granted on March 8, 2018. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:16 UTC |
Janish Ronald CraigEVP, Gbl Ops & SC & CTO
|
Tax withholdingOrdinary Shares | 1,179 | $41.82 | $49,305.78 |
DisclosureSEC source: 0001585364-21-000026 · wf-form4_161534258098002.xml · nonDerivative · entry 2 Janish Ronald Craig · CIK 0001679931 · EVP, Gbl Ops & SC & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,010 Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:16 UTC |
Janish Ronald CraigEVP, Gbl Ops & SC & CTO
|
GrantOrdinary Shares | 4,121 | $41.82 | $172,340.22 |
DisclosureSEC source: 0001585364-21-000026 · wf-form4_161534258098002.xml · nonDerivative · entry 1 Janish Ronald Craig · CIK 0001679931 · EVP, Gbl Ops & SC & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,189 F1 · kind: Vesting of performance-based restricted stock units granted on March 8, 2018. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:15 UTC |
Andersen SvendEVP & President CHCI
|
Tax withholdingOrdinary Shares | 47 | $41.82 | $1,965.54 |
DisclosureSEC source: 0001585364-21-000024 · wf-form4_161534253601854.xml · nonDerivative · entry 2 Andersen Svend · CIK 0001699722 · EVP & President CHCI 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,698 Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:15 UTC |
Andersen SvendEVP & President CHCI
|
GrantOrdinary Shares | 5,543 | $41.82 | $231,808.26 |
DisclosureSEC source: 0001585364-21-000024 · wf-form4_161534253601854.xml · nonDerivative · entry 1 Andersen Svend · CIK 0001699722 · EVP & President CHCI 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,745 F1 · kind: Vesting of performance-based restricted stock units granted on March 8, 2018. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:43 UTC |
ASHFORD ORLANDO DDirector
|
GrantRestricted Stock Units · Derivative | 2,984 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-21-000035 · wf-form4_161534419829110.xml · derivative · entry 2 ASHFORD ORLANDO D · CIK 0001445728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,984 Underlying: Ordinary Shares · 2,984 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 5 March 2022. F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 5 March 2022. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:18 UTC |
Sorota Richard SEVP & President CSCA
|
GrantRestricted Stock Units · Derivative | 10,965 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-21-000031 · wf-form4_161534270372208.xml · derivative · entry 3 Sorota Richard S · CIK 0001424327 · EVP & President CSCA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,965 Underlying: Ordinary Shares · 10,965 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:18 UTC |
Sorota Richard SEVP & President CSCA
|
Tax withholdingOrdinary Shares | 1,108 | $41.04 | $45,472.32 |
DisclosureSEC source: 0001585364-21-000031 · wf-form4_161534270372208.xml · nonDerivative · entry 2 Sorota Richard S · CIK 0001424327 · EVP & President CSCA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,161 Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:18 UTC |
Sorota Richard SEVP & President CSCA
|
Exercise / conversionOrdinary Shares | 2,540 | $41.04 | $104,241.60 |
DisclosureSEC source: 0001585364-21-000031 · wf-form4_161534270372208.xml · nonDerivative · entry 1 Sorota Richard S · CIK 0001424327 · EVP & President CSCA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of service-based restricted stock units granted on March 5, 2020. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:16 UTC |
KINGMA TODD WExecutive VP, General Counsel
|
GrantRestricted Stock Units · Derivative | 10,234 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-21-000025 · wf-form4_161534255990452.xml · derivative · entry 7 KINGMA TODD W · CIK 0001267878 · Executive VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,234 Underlying: Ordinary Shares · 10,234 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F4 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F5 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. F5 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:16 UTC |
KINGMA TODD WExecutive VP, General Counsel
|
Tax withholdingOrdinary Shares | 667 | $41.04 | $27,373.68 |
DisclosureSEC source: 0001585364-21-000025 · wf-form4_161534255990452.xml · nonDerivative · entry 6 KINGMA TODD W · CIK 0001267878 · Executive VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,856 Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:16 UTC |
KINGMA TODD WExecutive VP, General Counsel
|
Exercise / conversionOrdinary Shares | 2,540 | $41.04 | $104,241.60 |
DisclosureSEC source: 0001585364-21-000025 · wf-form4_161534255990452.xml · nonDerivative · entry 5 KINGMA TODD W · CIK 0001267878 · Executive VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of service-based restricted stock units granted on March 5, 2020. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:16 UTC |
KINGMA TODD WExecutive VP, General Counsel
|
Tax withholdingOrdinary Shares | 777 | $41.04 | $31,888.08 |
DisclosureSEC source: 0001585364-21-000025 · wf-form4_161534255990452.xml · nonDerivative · entry 4 KINGMA TODD W · CIK 0001267878 · Executive VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,983 Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:16 UTC |
KINGMA TODD WExecutive VP, General Counsel
|
Exercise / conversionOrdinary Shares | 2,960 | $41.04 | $121,478.40 |
DisclosureSEC source: 0001585364-21-000025 · wf-form4_161534255990452.xml · nonDerivative · entry 3 KINGMA TODD W · CIK 0001267878 · Executive VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Vesting of service-based restricted stock units granted on March 6, 2019. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:19 UTC |
KESSLER MURRAY SDirector · CEO
|
GrantRestricted Stock Units · Derivative | 56,652 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-21-000034 · wf-form4_161534277497380.xml · derivative · entry 5 KESSLER MURRAY S · CIK 0001208563 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,652 Underlying: Ordinary Shares · 56,652 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F4 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. F4 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:19 UTC |
KESSLER MURRAY SDirector · CEO
|
Tax withholdingOrdinary Shares | 5,683 | $41.04 | $233,230.32 |
DisclosureSEC source: 0001585364-21-000034 · wf-form4_161534277497380.xml · nonDerivative · entry 4 KESSLER MURRAY S · CIK 0001208563 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,847 Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:19 UTC |
KESSLER MURRAY SDirector · CEO
|
Exercise / conversionOrdinary Shares | 14,061 | $41.04 | $577,063.44 |
DisclosureSEC source: 0001585364-21-000034 · wf-form4_161534277497380.xml · nonDerivative · entry 3 KESSLER MURRAY S · CIK 0001208563 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Vesting of service-based restricted stock units granted on March 5, 2020. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:19 UTC |
KESSLER MURRAY SDirector · CEO
|
Tax withholdingOrdinary Shares | 6,623 | $41.04 | $271,807.92 |
DisclosureSEC source: 0001585364-21-000034 · wf-form4_161534277497380.xml · nonDerivative · entry 2 KESSLER MURRAY S · CIK 0001208563 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,103 Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:19 UTC |
KESSLER MURRAY SDirector · CEO
|
Exercise / conversionOrdinary Shares | 16,385 | $41.04 | $672,440.40 |
DisclosureSEC source: 0001585364-21-000034 · wf-form4_161534277497380.xml · nonDerivative · entry 1 KESSLER MURRAY S · CIK 0001208563 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of service-based restricted stock units granted on March 6, 2019. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:19 UTC |
SILCOCK RAYMONDEVP, Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 14,620 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-21-000032 · wf-form4_161534273053698.xml · derivative · entry 2 SILCOCK RAYMOND · CIK 0001189768 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,620 Underlying: Ordinary Shares · 14,620 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:19 UTC |
SILCOCK RAYMONDEVP, Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 3,629 | $41.04 | $148,934.16 |
DisclosureSEC source: 0001585364-21-000032 · wf-form4_161534273053698.xml · nonDerivative · entry 1 SILCOCK RAYMOND · CIK 0001189768 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: Vesting of service-based restricted stock units granted on March 5, 2020. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:19 UTC |
Kochan SharonEVP & President Rx
|
GrantRestricted Stock Units · Derivative | 8,041 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-21-000033 · wf-form4_161534275115528.xml · derivative · entry 4 Kochan Sharon · CIK 0001398274 · EVP & President Rx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,041 Underlying: Ordinary Shares · 8,041 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F4 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F5 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. F5 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:19 UTC |
Kochan SharonEVP & President Rx
|
Exercise / conversionOrdinary Shares | 1,996 | $41.04 | $81,915.84 |
DisclosureSEC source: 0001585364-21-000033 · wf-form4_161534275115528.xml · nonDerivative · entry 3 Kochan Sharon · CIK 0001398274 · EVP & President Rx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of service-based restricted stock units granted on March 5, 2020. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:19 UTC |
Kochan SharonEVP & President Rx
|
Exercise / conversionOrdinary Shares | 2,061 | $41.04 | $84,583.44 |
DisclosureSEC source: 0001585364-21-000033 · wf-form4_161534275115528.xml · nonDerivative · entry 2 Kochan Sharon · CIK 0001398274 · EVP & President Rx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Vesting of service-based restricted stock units granted on March 6, 2019. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:18 UTC |
Farrington ThomasEVP and CIO
|
GrantRestricted Stock Units · Derivative | 5,080 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-21-000030 · wf-form4_161534267503733.xml · derivative · entry 7 Farrington Thomas · CIK 0001398276 · EVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,080 Underlying: Ordinary Shares · 5,080 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F4 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F5 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. F5 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:18 UTC |
Farrington ThomasEVP and CIO
|
Tax withholdingOrdinary Shares | 640 | $41.04 | $26,265.60 |
DisclosureSEC source: 0001585364-21-000030 · wf-form4_161534267503733.xml · nonDerivative · entry 6 Farrington Thomas · CIK 0001398276 · EVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,828 Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:18 UTC |
Farrington ThomasEVP and CIO
|
Exercise / conversionOrdinary Shares | 1,261 | $41.04 | $51,751.44 |
DisclosureSEC source: 0001585364-21-000030 · wf-form4_161534267503733.xml · nonDerivative · entry 5 Farrington Thomas · CIK 0001398276 · EVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of service-based restricted stock units granted on March 5, 2020. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:18 UTC |
Farrington ThomasEVP and CIO
|
Tax withholdingOrdinary Shares | 607 | $41.04 | $24,911.28 |
DisclosureSEC source: 0001585364-21-000030 · wf-form4_161534267503733.xml · nonDerivative · entry 4 Farrington Thomas · CIK 0001398276 · EVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,207 Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:18 UTC |
Farrington ThomasEVP and CIO
|
Exercise / conversionOrdinary Shares | 1,469 | $41.04 | $60,287.76 |
DisclosureSEC source: 0001585364-21-000030 · wf-form4_161534267503733.xml · nonDerivative · entry 3 Farrington Thomas · CIK 0001398276 · EVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Vesting of service-based restricted stock units granted on March 6, 2019. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Dillard James E IIIEVP, Chief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 8,041 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-21-000029 · wf-form4_161534265554148.xml · derivative · entry 5 Dillard James E III · CIK 0001626841 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,041 Underlying: Ordinary Shares · 8,041 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F4 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. F4 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Dillard James E IIIEVP, Chief Scientific Officer
|
Tax withholdingOrdinary Shares | 570 | $41.04 | $23,392.80 |
DisclosureSEC source: 0001585364-21-000029 · wf-form4_161534265554148.xml · nonDerivative · entry 4 Dillard James E III · CIK 0001626841 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,603 Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Dillard James E IIIEVP, Chief Scientific Officer
|
Exercise / conversionOrdinary Shares | 1,996 | $41.04 | $81,915.84 |
DisclosureSEC source: 0001585364-21-000029 · wf-form4_161534265554148.xml · nonDerivative · entry 3 Dillard James E III · CIK 0001626841 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Vesting of service-based restricted stock units granted on March 5, 2020. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Dillard James E IIIEVP, Chief Scientific Officer
|
Tax withholdingOrdinary Shares | 666 | $41.04 | $27,332.64 |
DisclosureSEC source: 0001585364-21-000029 · wf-form4_161534265554148.xml · nonDerivative · entry 2 Dillard James E III · CIK 0001626841 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,177 Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Dillard James E IIIEVP, Chief Scientific Officer
|
Exercise / conversionOrdinary Shares | 2,326 | $41.04 | $95,459.04 |
DisclosureSEC source: 0001585364-21-000029 · wf-form4_161534265554148.xml · nonDerivative · entry 1 Dillard James E III · CIK 0001626841 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of service-based restricted stock units granted on March 6, 2019. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Willis RobertEVP & CHRO
|
GrantRestricted Stock Units · Derivative | 3,838 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-21-000028 · wf-form4_161534262842908.xml · derivative · entry 11 Willis Robert · CIK 0001770124 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,838 Underlying: Ordinary Shares · 3,838 shares Expires not disclosed F6 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F6 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F7 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. F7 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Willis RobertEVP & CHRO
|
Tax withholdingOrdinary Shares | 496 | $41.04 | $20,355.84 |
DisclosureSEC source: 0001585364-21-000028 · wf-form4_161534262842908.xml · nonDerivative · entry 10 Willis Robert · CIK 0001770124 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,292 Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Willis RobertEVP & CHRO
|
Exercise / conversionOrdinary Shares | 953 | $41.04 | $39,111.12 |
DisclosureSEC source: 0001585364-21-000028 · wf-form4_161534262842908.xml · nonDerivative · entry 9 Willis Robert · CIK 0001770124 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Vesting of service-based restricted stock units granted on March 5, 2020. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Willis RobertEVP & CHRO
|
Tax withholdingOrdinary Shares | 286 | $41.04 | $11,737.44 |
DisclosureSEC source: 0001585364-21-000028 · wf-form4_161534262842908.xml · nonDerivative · entry 8 Willis Robert · CIK 0001770124 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,835 Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Willis RobertEVP & CHRO
|
Exercise / conversionOrdinary Shares | 550 | $41.04 | $22,572.00 |
DisclosureSEC source: 0001585364-21-000028 · wf-form4_161534262842908.xml · nonDerivative · entry 7 Willis Robert · CIK 0001770124 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: Vesting of service-based restricted stock units granted on March 6, 2019. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Willis RobertEVP & CHRO
|
Tax withholdingOrdinary Shares | 302 | $41.04 | $12,394.08 |
DisclosureSEC source: 0001585364-21-000028 · wf-form4_161534262842908.xml · nonDerivative · entry 4 Willis Robert · CIK 0001770124 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,237 Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Willis RobertEVP & CHRO
|
Exercise / conversionOrdinary Shares | 580 | $41.04 | $23,803.20 |
DisclosureSEC source: 0001585364-21-000028 · wf-form4_161534262842908.xml · nonDerivative · entry 3 Willis Robert · CIK 0001770124 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Vesting of service-based restricted stock units granted on August 15, 2019. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Quinn GrainneEVP, Chief Medical Officer
|
GrantRestricted Stock Units · Derivative | 4,751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-21-000027 · wf-form4_161534260400653.xml · derivative · entry 7 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,751 Underlying: Ordinary Shares · 4,751 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F4 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F5 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. F5 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Quinn GrainneEVP, Chief Medical Officer
|
Tax withholdingOrdinary Shares | 548 | $41.04 | $22,489.92 |
DisclosureSEC source: 0001585364-21-000027 · wf-form4_161534260400653.xml · nonDerivative · entry 6 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,751 Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC |
Quinn GrainneEVP, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,053 | $41.04 | $43,215.12 |
DisclosureSEC source: 0001585364-21-000027 · wf-form4_161534260400653.xml · nonDerivative · entry 5 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of service-based restricted stock units granted on March 5, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.